Furthermore, the AML+CYT group that was treated with GCSF (GCSF+AML+CYT) showed a similar ratio of testis weight/body weight compared to the AML+CYT group after 4 weeks of treatment (Figure 2B). This evidence concerns the gene CSF3 and acute myeloid leukemia.